О. М. Моисеева

12.8k total citations · 2 hit papers
188 papers, 2.1k citations indexed

About

О. М. Моисеева is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, О. М. Моисеева has authored 188 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 98 papers in Cardiology and Cardiovascular Medicine, 94 papers in Pulmonary and Respiratory Medicine and 36 papers in Molecular Biology. Recurrent topics in О. М. Моисеева's work include Pulmonary Hypertension Research and Treatments (67 papers), Cardiovascular Function and Risk Factors (21 papers) and Cardiac Valve Diseases and Treatments (17 papers). О. М. Моисеева is often cited by papers focused on Pulmonary Hypertension Research and Treatments (67 papers), Cardiovascular Function and Risk Factors (21 papers) and Cardiac Valve Diseases and Treatments (17 papers). О. М. Моисеева collaborates with scholars based in Russia, United States and Italy. О. М. Моисеева's co-authors include Richard N. Channick, Nazzareno Galiè, Vallerie V. McLaughlin, Ioana R. Preston, Robert P. Frantz, Ekkehard Grünig, Zhi‐Cheng Jing, Tomás Pulido, Zeenat Safdar and Yuichi Tamura and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

О. М. Моисеева

152 papers receiving 2.0k citations

Hit Papers

Selexipag for the Treatment of Pulmonary Arterial Hyperte... 2015 2026 2018 2022 2015 2018 200 400 600

Peers

О. М. Моисеева
Ralph Preiss United States
О. М. Моисеева
Citations per year, relative to О. М. Моисеева О. М. Моисеева (= 1×) peers Ralph Preiss

Countries citing papers authored by О. М. Моисеева

Since Specialization
Citations

This map shows the geographic impact of О. М. Моисеева's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by О. М. Моисеева with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites О. М. Моисеева more than expected).

Fields of papers citing papers by О. М. Моисеева

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by О. М. Моисеева. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by О. М. Моисеева. The network helps show where О. М. Моисеева may publish in the future.

Co-authorship network of co-authors of О. М. Моисеева

This figure shows the co-authorship network connecting the top 25 collaborators of О. М. Моисеева. A scholar is included among the top collaborators of О. М. Моисеева based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with О. М. Моисеева. О. М. Моисеева is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Чазова, И Е, T. V. Martynyuk, С. Н. Авдеев, et al.. (2025). Expert consensus on approaches to risk stratification and choice of therapy in patients with inoperable and residual chronic thromboembolic pulmonary hypertension. Terapevticheskii arkhiv. 97(3). 279–288.
3.
Моисеева, О. М., et al.. (2024). Carlino-Like Technique for Retrograde Recanalization of Chronic Thromboembolic Pulmonary Artery Occlusion. JACC: Cardiovascular Interventions. 17(11). 1394–1396. 2 indexed citations
4.
Kopeć, Grzegorz, Paul R. Forfia, Kohtaro Abe, et al.. (2024). Recognition, diagnosis, and operability assessment of chronic thromboembolic pulmonary hypertension (CTEPH): A global cross‐sectional scientific survey (CLARITY). Pulmonary Circulation. 14(1). e12330–e12330. 6 indexed citations
5.
Skoro‐Sajer, Nika, Karen Sheares, Paul R. Forfia, et al.. (2024). Treatment and management of chronic thromboembolic pulmonary hypertension (CTEPH): A global cross‐sectional scientific survey (CLARITY). Pulmonary Circulation. 14(2). e12406–e12406. 1 indexed citations
6.
Моисеева, О. М., et al.. (2024). Assessment of central hemodynamic parameters after pulmonary thrombendarterectomy in patients with chronic thromboembolic pulmonary hypertension. Russian Journal of Cardiology and Cardiovascular Surgery. 17(6). 637–637.
7.
Irtyuga, O. B., S. I. Tarnovskaya, О. М. Моисеева, et al.. (2024). The Role of NOTCH Pathway Genes in the Inherited Susceptibility to Aortic Stenosis. Journal of Cardiovascular Development and Disease. 11(7). 226–226. 2 indexed citations
8.
Kostareva, Anna, et al.. (2023). Association between traditional cardiovascular risk factors and clinical phenotype of hypertrophic cardiomyopathy. Arterial’naya Gipertenziya (Arterial Hypertension). 29(4). 371–379. 1 indexed citations
9.
Галагудза, М. М., et al.. (2023). INCREASED LEVELS OF PROINFLAMMATORY CYTOKINES IN BLOOD PLASMA IN PATIENTS WITH CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION. Complex Issues of Cardiovascular Diseases. 12(4). 29–42.
10.
Карпов, А. А., et al.. (2022). Inhibition of JAK1,2 Prevents Fibrotic Remodeling of Pulmonary Vascular Bed and Improves Outcomes in the Rat Model of Chronic Thromboembolic Pulmonary Hypertension. International Journal of Molecular Sciences. 23(24). 15646–15646. 9 indexed citations
11.
Терещенко, С. Н., И. В. Жиров, О. М. Моисеева, et al.. (2022). Practical guidelines for the diagnosis and treatment of transthyretin amyloid cardiomyopathy (ATTR-CM or transthyretin cardiac amyloidosis). Terapevticheskii arkhiv. 94(4). 584–595. 8 indexed citations
13.
Lomakin, N. V., Д. Н. Проценко, Mazurov Vi, et al.. (2021). The efficacy and safety of levilimab in severely ill COVID-19 patients not requiring mechanical ventilation: results of a multicenter randomized double-blind placebo-controlled phase III CORONA clinical study. Inflammation Research. 70(10-12). 1233–1246. 35 indexed citations
14.
Баутин, А. Е., et al.. (2019). On the possibility to increase sensitivity of diagnostic tests for fixed pulmonary hypertension in heart transplant candidates. SHILAP Revista de lepidopterología. 47(3). 212–220. 2 indexed citations
15.
Моисеева, О. М., et al.. (2019). Idiopathic recurrent pericarditis — a paradigm shift?. SHILAP Revista de lepidopterología. 155–163. 4 indexed citations
16.
Моисеева, О. М., et al.. (2018). SEARCH FOR CLINICAL PREDICTORS OF PULMONARY HYPERTENSION IN PATIENTS WITH SYSTEMIC SCLEROSIS. SHILAP Revista de lepidopterología. 1 indexed citations
17.
Irtyuga, O. B., Anna Malashicheva, S. I. Tarnovskaya, et al.. (2018). ROLE OF THE NOTCH1 GENE IN FORMATION OF AORTIC ANEURYSM. Russian Journal of Cardiology. 53–59. 2 indexed citations
18.
Головкин, А. С., et al.. (2017). PURINERGIC SIGNALING RECEPTORS EXPRESSION ON PERIPHERAL T-LYMPHOCYTES OF HEALTHY DONORS. 4(5). 46–60. 4 indexed citations
19.
Irtyuga, O. B., et al.. (2013). Pathogenetic mechanisms of ascending aortic aneurysm of varied aetiology. SHILAP Revista de lepidopterología. 1 indexed citations
20.
Моисеева, О. М., et al.. (2012). Comparative analysis of the serum level of autoantibodies as a diagnostic tool of myocardial inflammatory diseases. SHILAP Revista de lepidopterología. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026